DiagnaMed Holdings Corp. engages in providing artificial intelligence (AI) healthcare solutions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-11-08. The firm delivers technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and artificial intelligence (AI)-driven drug discovery and diagnostics. The firm is focused on the commercialization of two technologies, such as a proprietary electromagnetic heating technology enabling hydrogen production from petroleum reservoirs and natural hydrogen fields, and BRAIN AGE BRAIN HEALTH, a proprietary brain health AI platform for the healthcare market. Its Brain Tremor is an investigating technological application that monitors, collects and uses individual information to detect tremors, and measure cognitive and brain activity in patients with neurological disorders. BRAIN AGE Brain Health is a brain health AI platform that aims to predict and monitor brain age and provide actionable insights into mental health and neurodegenerative disorders.
Follow-Up Questions
DiagnaMed Holdings Corp의 CEO는 누구입니까?
Mr. Fabio Chianelli은 2021부터 회사에 합류한 DiagnaMed Holdings Corp의 Chairman of the Board입니다.
DGNMF 주식의 가격 성능은 어떻습니까?
DGNMF의 현재 가격은 $0.066이며, 전 거래일에 decreased 0% 하였습니다.
DiagnaMed Holdings Corp의 주요 사업 주제나 업종은 무엇입니까?
DiagnaMed Holdings Corp은 N/A 업종에 속하며, 해당 부문은 N/A입니다
